JOHANNESBURG, March 12 (Reuters) – South Africa’s medicines regulator SAHPRA said on Friday that it had received documentation for the COVID-19 vaccine developed by China’s Sinovac.
It added in a statement that it would now start evaluating the data and assessing the efficacy of the vaccine. (Reporting by Alexander Winning; Editing by Christopher Cushing)
(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html